1 |
Melch M, Lee J, Jomphe C, Robbie GJ. Population Pharmacokinetic Analysis of the RNAi Therapeutic Givosiran in Patients with Acute Hepatic Porphyria. Clin Pharmacokinet 2023;62:89-99. [PMID: 36633811 DOI: 10.1007/s40262-022-01197-0] [Reference Citation Analysis]
|
2 |
Zübarioğlu T, Kıykım E, Aktuğlu-Zeybek Ç. An Overview of Acute Hepatic Porphyrias: Clinical Implications, Diagnostic Approaches, and Management Strategies. Turk Arch Pediatr 2023;58:3-9. [PMID: 36598205 DOI: 10.5152/TurkArchPediatr.2022.22301] [Reference Citation Analysis]
|
3 |
Ricci A, Di Betto G, Bergamini E, Buzzetti E, Corradini E, Ventura P. Iron Metabolism in the Disorders of Heme Biosynthesis. Metabolites 2022;12:819. [DOI: 10.3390/metabo12090819] [Reference Citation Analysis]
|
4 |
Ricci A, Sandri G, Marcacci M, Di Pierro E, Granata F, Cuoghi C, Marchini S, Pietrangelo A, Ventura P. Endothelial Dysfunction in Acute Hepatic Porphyrias. Diagnostics 2022;12:1303. [DOI: 10.3390/diagnostics12061303] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
5 |
Marcacci M, Ricci A, Cuoghi C, Marchini S, Pietrangelo A, Ventura P. Challenges in diagnosis and management of acute hepatic porphyrias: from an uncommon pediatric onset to innovative treatments and perspectives. Orphanet J Rare Dis 2022;17:160. [PMID: 35392955 DOI: 10.1186/s13023-022-02314-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|